402 related articles for article (PubMed ID: 17124180)
1. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells.
Estève PO; Chin HG; Pradhan S
J Biol Chem; 2007 Jan; 282(4):2615-25. PubMed ID: 17124180
[TBL] [Abstract][Full Text] [Related]
2. DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation.
Milutinovic S; Brown SE; Zhuang Q; Szyf M
J Biol Chem; 2004 Jul; 279(27):27915-27. PubMed ID: 15087453
[TBL] [Abstract][Full Text] [Related]
3. DNA damage-induced down-regulation of human Cdc25C and Cdc2 is mediated by cooperation between p53 and maintenance DNA (cytosine-5) methyltransferase 1.
Le Gac G; Estève PO; Ferec C; Pradhan S
J Biol Chem; 2006 Aug; 281(34):24161-70. PubMed ID: 16807237
[TBL] [Abstract][Full Text] [Related]
4. Regulation of transcription of the Dnmt1 gene by Sp1 and Sp3 zinc finger proteins.
Kishikawa S; Murata T; Kimura H; Shiota K; Yokoyama KK
Eur J Biochem; 2002 Jun; 269(12):2961-70. PubMed ID: 12071960
[TBL] [Abstract][Full Text] [Related]
5. Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter.
Chun JY; Hu Y; Pinder E; Wu J; Li F; Gao AC
Mol Cancer Ther; 2007 Sep; 6(9):2572-80. PubMed ID: 17876054
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of p53/Sp1 control leads to DNA methyltransferase-1 overexpression in lung cancer.
Lin RK; Wu CY; Chang JW; Juan LJ; Hsu HS; Chen CY; Lu YY; Tang YA; Yang YC; Yang PC; Wang YC
Cancer Res; 2010 Jul; 70(14):5807-17. PubMed ID: 20570896
[TBL] [Abstract][Full Text] [Related]
7. Sp1 and Sp3 regulate basal transcription of the survivin gene.
Xu R; Zhang P; Huang J; Ge S; Lu J; Qian G
Biochem Biophys Res Commun; 2007 Apr; 356(1):286-92. PubMed ID: 17350596
[TBL] [Abstract][Full Text] [Related]
8. Mutant p53 binds to estrogen receptor negative promoter via DNMT1 and HDAC1 in MDA-MB-468 breast cancer cells.
Arabsolghar R; Azimi T; Rasti M
Mol Biol Rep; 2013 Mar; 40(3):2617-25. PubMed ID: 23242655
[TBL] [Abstract][Full Text] [Related]
9. Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters.
Estève PO; Chin HG; Pradhan S
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1000-5. PubMed ID: 15657147
[TBL] [Abstract][Full Text] [Related]
10. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
Zhao S; Venkatasubbarao K; Li S; Freeman JW
Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
[TBL] [Abstract][Full Text] [Related]
11. The human receptor tyrosine kinase Axl gene--promoter characterization and regulation of constitutive expression by Sp1, Sp3 and CpG methylation.
Mudduluru G; Allgayer H
Biosci Rep; 2008 Jun; 28(3):161-76. PubMed ID: 18522535
[TBL] [Abstract][Full Text] [Related]
12. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex.
Choi HS; Lee JH; Park JG; Lee YI
Biochem Biophys Res Commun; 2002 Aug; 296(4):1005-12. PubMed ID: 12200149
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
[TBL] [Abstract][Full Text] [Related]
14. Control elements of Dnmt1 gene are regulated in cell-cycle dependent manner.
Kishikawa S; Murata T; Ugai H; Yamazaki T; Yokoyama KK
Nucleic Acids Res Suppl; 2003; (3):307-8. PubMed ID: 14510503
[TBL] [Abstract][Full Text] [Related]
15. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
Zhang Y; Dufau ML
J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
[TBL] [Abstract][Full Text] [Related]
16. Induction of truncated form of tenascin-X (XB-S) through dissociation of HDAC1 from SP-1/HDAC1 complex in response to hypoxic conditions.
Kato A; Endo T; Abiko S; Ariga H; Matsumoto K
Exp Cell Res; 2008 Aug; 314(14):2661-73. PubMed ID: 18588874
[TBL] [Abstract][Full Text] [Related]
17. CD1d induction in solid tumor cells by histone deacetylase inhibitors through inhibition of HDAC1/2 and activation of Sp1.
Yang PM; Lin PJ; Chen CC
Epigenetics; 2012 Apr; 7(4):390-9. PubMed ID: 22419072
[TBL] [Abstract][Full Text] [Related]
18. Elevated histone H3 acetylation and loss of the Sp1-HDAC1 complex de-repress the GM2-synthase gene in renal cell carcinoma.
Banerjee A; Mahata B; Dhir A; Mandal TK; Biswas K
J Biol Chem; 2019 Jan; 294(3):1005-1018. PubMed ID: 30463940
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of human topoisomerase IIalpha expression correlates with relative amounts of specificity factors Sp1 and Sp3 bound at proximal and distal promoter regions.
Williams AO; Isaacs RJ; Stowell KM
BMC Mol Biol; 2007 May; 8():36. PubMed ID: 17511886
[TBL] [Abstract][Full Text] [Related]
20. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
Huang L; Sowa Y; Sakai T; Pardee AB
Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
